NeuroBo Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NeuroBo Pharmaceuticals, Inc.
CIK #0001638287, 0001784036
EDGAR Form CIK 2011 - 2025
10-K [0001638287]
10-Q [0001638287]
3 [0001638287]
4 [0001638287]
8-K [0001638287]
D [0001638287]
SC 13D [0001638287]
SC 13G [0001638287]
SC 13D [0001784036]
Form 13D/13G Filer Form 13D/13G Subject Filed
Armistice Capital LLC Metavia Inc [2025-02-14]
Armistice Capital LLC Neurobo Pharmaceuticals Inc [2024-11-14]
Strategic Risk LLC Neurobo Pharmaceuticals Inc [2023-03-28]
Altium Capital Management LP Neurobo Pharmaceuticals Inc [2022-11-17]
Dong-A St Co Ltd Neurobo Pharmaceuticals Inc [2021-03-11]
Freeman Roy Lester Neurobo Pharmaceuticals Inc [2020-02-13]
JK Biopharma Solutions Inc Neurobo Pharmaceuticals Inc [2020-01-10]
E&Investment Inc Neurobo Pharmaceuticals Inc [2020-01-10]
Dong-A St Co Ltd Neurobo Pharmaceuticals Inc [2020-01-09]
Neurobo Pharmaceuticals Inc Gemphire Therapeutics Inc [2019-08-02]
View All
Form 3/4/5 Subject 2011 - 2025
Woodworth Marshall H
MetaVia Inc.
Tursi James Patrick
Strickland D Gordon
Koven Andrew I
Salsbury Michael
Groves Jason L
Glickman Mark A
Dong-A St Co Ltd
Kim Hyung Heon
Kim Na Yeon
Hooker Joseph
Goldman Sachs Group Inc
Goldman Sachs & Co LLC
E&Investment, Inc.
E&Healthcare Investment Fund II
Kang Richard
Price Ben Gil
Bakshi Akash
Swirsky Douglas J
Gullans Steven R. Ph.D.
Jeong Tae Heum
Oh Jeong Gyun
JK BioPharma Solutions, Inc
Versavel Mark
Shannon Nicola
Lichtinger Pedro
Sassine Andy
Kousky Kenneth W
Reno Seth
Bisgaier Charles PhD
Golden Lee Scott
Mathiesen Jeffrey S
Hawryluk P. Kent
Sooch Mina
Lowenschuss David
Oniciu Carmen Daniela
Terms | Privacy | Guide
tony@aum13f.com